Introduction
Activity Introduction (Brief) Build awareness and knowledge on unique Mounjaro Mode of Action, provide overview of clinical trial program with dive in on key efficacy data and the way how to start patient like Julia on treatment with Mounjaro.
Objectives
Activity Introduction (Brief) Build awareness and knowledge on unique Mounjaro Mode of Action, provide overview of clinical trial program with dive in on key efficacy data and the way how to start patient like Julia on treatment with Mounjaro.
This Course For :
Physician
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General Practitioners )
Resident / Fellow
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General Practitioners )
Speaker
Prof. Naveed Sattar
Professor of Metabolic Medicine University Glasgow Associate Editor for Diabetes Care
Dr. Bruno Halpern
Chief-Director, Obesity Centre, Hospital 9 de Julho, São Paulo
Prof. Dr. Juris J. Meier
Researcher, Diabetes Center Bochum-Hattingen, St. Josef Hospital, Bochum
Dr. Santiago Tofé Keynote
Sr. Consultant, Dep. of Endocrinology, Uni. Hospital Son Espases, Ass. Professor University Illes Balears
Dr. Jonathan Rachman
Associate VP Medical Affairs ITAL Diabetes Eli Lilly and Company
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
22 Nov 2023 To 22 Nov 2023 -
03:30 PM To 04:30 PM 
Certificate Available 
Online Click Here
- 509
Add to Calendar
11/22/2023 03:30 PM
11/22/2023 04:30 PM
Asia/ Riyadh
Mounjaro: The First GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Treatment !
Mounjaro: The First GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Treatment !
https://medicalacademy.org/portal/event/view/2069
